INDIVA Revenue and Competitors

London, ON CAN

Location

$45.2M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • INDIVA's estimated annual revenue is currently $33.5M per year.(i)
  • INDIVA's estimated revenue per employee is $270,000
  • INDIVA's total funding is $45.2M.

Employee Data

  • INDIVA has 124 Employees.(i)
  • INDIVA grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.4M53-59%$9.2MN/A
#2
$149.5M4437%N/AN/A
#3
$149.9M44415%N/AN/A
#4
$9.7M45-31%N/AN/A
#5
N/A0N/A$7.7MN/A
#6
$2.6M160%N/AN/A
#7
$137.7M40826%N/AN/A
#8
$26.2M9724%N/AN/A
#9
$568.6M894-19%$4.5BN/A
#10
$65.6M2213%N/AN/A
Add Company

INDIVA is a Licensed Producer of medical cannabis certified under Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). Founded on a history of compassion, we provide Canadians with high-quality, consistent medical cannabis. INDIVA is working to become a global cannabis brand by combining commitment to client care, an internationally-recognized and award-winning grow-team, and GMP-compliant quality assurance standard operating procedures.

keywords:N/A

$45.2M

Total Funding

124

Number of Employees

$33.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

INDIVA News

2022-04-20 - Indiva to hold Investor Update Webinar, Monday May 2

Indiva to hold Investor Update Webinar, Monday May 2. April 28, 2022 1:01 PM. Vancouver, British Columbia--(Newsfile Corp. - April 28, 2022) - Investor.

2022-04-19 - Indiva Limited Continues To Fly Under Investors Radar ...

Although Indiva has been one of the most significant growth stories in the Canadian cannabis industry, the business receives minimal coverage...

2022-04-17 - INDIVA REPORTS RECORD FOURTH QUARTER AND ...

Indiva Remains the National Market Share Leader in the Edibles Category. LONDON, ON, April 26, 2022 /PRNewswire/ - Indiva Limited (the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.3M124-26%$40M
#2
$15M12412%N/A
#3
$18.6M1249%N/A
#4
$18M12415%N/A
#5
$40.7M12431%N/A